Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Vertex Pharmaceuticals Inc. buy JPMorgan Chase & Co.

Start price
€432.30
17:00 / 50%
Target price
€464.36
05.08.25
Performance (%)
0.39%
Price
€434.00
19:13
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Vertex Pharmaceuticals Inc. is nearly unchanged. This prediction currently runs until 05.08.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w
Vertex Pharmaceuticals Inc. 0.39%
iShares Core DAX® -3.935%
iShares Nasdaq 100 -3.608%
iShares Nikkei 225® -4.513%
iShares S&P 500 -2.607%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 0.39%
Target price 464.355
Change
Ends at 05.08.25

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at JPMorgan Chase & Co. from $505.00 to $510.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat

Stopped prediction by JPMorgan_Chase___Co_ for Vertex Pharmaceuticals Inc.

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€400.30
01.02.24
€404.41
01.02.25
9.19%
19:13